Kripa Devrakhanda
Analyst
Truist Securities
Equibles does not estimate personal net worth.
About Kripa Devrakhanda
Kripa Devrakhanda is recorded as Analyst at Truist Securities. Kripa Devrakhanda has spoken on 1 earnings call across 1 company, most recently for Madrigal Pharmaceuticals, Inc. on July 30, 2026. The companies whose calls Kripa Devrakhanda spoke on are classified in the Healthcare sector.
Kripa Devrakhanda on recent calls
“I wanted to ask about the competitive landscape. Now, as we get closer to a competitor phase three data in 4Q of this year, I was wondering if you can comment on how you view any potential impact on RISDifera, you know, the trial were to be successful, and MASH patients get another oral option.”
Affiliation history
-
Truist Securities
Analyst
Transcript header (unverified)
Current